Steven Henck
About
Steven Henck is from Redwood City, California, United States. Steven works in the following industries: "Semiconductors", and "Biotechnology". Steven is currently Vice President, R&D at Integrated DNA Technologies, located in Redwood City, CA. In Steven's previous role as a Head of External Innovation, Roche Sequencing Solutions; Site Head Roche Diagnostics Santa Clara at Roche, Steven worked in Santa Clara, CA until Mar 2019. Prior to joining Roche, Steven was a Life Cycle Leader at Roche Sequencing Solutions and held the position of Life Cycle Leader at Santa Clara, CA. Prior to that, Steven was a Vice President at 454 Life Sciences, based in Branford, CT from Nov 2010 to Jun 2014. Steven started working as Founder, President & CEO at Arbor Fuel Inc. in Woodbridge, CT in Sep 2007. From Mar 1997 to Aug 2007, Steven was Senior Vice President of Operations at CuraGen Corporation, based in Branford, CT. Prior to that, Steven was a Member, Group Technical Staff at Texas Instruments, based in Dallas/Fort Worth Area from Feb 1990 to Feb 1997.
You can find Steven Henck's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Steven Henck's current jobs
Responsible for research, development, verification and validation of NGS and PCR products.
Steven Henck's past jobs
Lead a highly-effective, cross-functional lifecycle team and manage strategic portfolio of products from concept to obsolescence, including all activities related to development, approval, launch and commercialization -- ultimately responsible for successful execution. Develop and implement strategic plans; ownership of all initiatives within segment; meeting milestones on time and within the resources. Single point of accountability for Roche’s long-term success.
Cross-functional Project Leader for sequencing project teams from initiation through post-launch review.
Arbor Fuel used the power of biotechnology to develop yeast strains and processes for the commercial production of next-generation alternative fuels. The microbes that we developed use cellulosic biomass as an environmental sensitive and economically sensible of feedstock for fuel production.
Senior manager responsible for process development, technology transfer, and manufacturing processes for the production of recombinant protein and antibody therapeutics for clinical and pre-clinical trials. Responsible for staff of 35 people in the following departments: Cell Line Development; Expression, Purification; Formulation; Analytical Methods Development and Quality Control. Reporting to EVP & CMO.
Developed materials, deposition processes and metrology tools for organic/polymer and inorganic lubricating films used on micromachined Digital Light Processing (DLP) chips.